Rodrigo Ochoa

Dr. Rodrigo Ochoa

Computational Drug Design, Novo Nordisk (Denmark), Copenhagen, Hovedstaden, Denmark
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2016 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
Rodrigo OchoaRodrigo Ochoa
Rodrigo Ochoa
SWStanley J. Watowich
Stanley J. Watowich
AFAndrés Flórez
Andrés Flórez
CMCarol V. Mesa
Carol V. Mesa
SRSara M. Robledo
Sara M. Robledo
CMCarlos Muskus
Carlos Muskus

10 July 2019 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
Rodrigo OchoaRodrigo Ochoa
Rodrigo Ochoa
ALAlessandro Laio
Alessandro Laio
Pilar CossioPilar Cossio
Pilar Cossio

15 September 2021 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
Rodrigo OchoaRodrigo Ochoa
Rodrigo Ochoa
KPKaren Palacio-Rodriguez
Karen Palacio-Rodriguez
CCCamila Mara Clemente
Camila Mara Clemente
NANatalia S. Adler
Natalia S. Adler

2 April 2019 in Molecules
Verified
Journal Article
Open access
PDF file
VLVicky Roa Linares
Vicky Roa Linares
YBYaneth Brand YM Miranda Brand
Yaneth Brand YM Miranda Brand
VTVerónica Tangarife-Castaño
Verónica Tangarife-Castaño
Rodrigo OchoaRodrigo Ochoa
Rodrigo Ochoa
PGPablo Anselmo García García
Pablo Anselmo García García
AFArturo San Feliciano
Arturo San Feliciano
Quinones are secondary metabolites of higher plants associated with many biological activities, including antiviral effects and cytotoxicity. In this study, the anti-herpetic and anti-dengue evaluation of 27 terpenyl-1,4-naphthoquinone (NQ), 1,4-anthraquinone (AQ) and heterocycle-fused quinone (HetQ) derivatives was done in vitro against Human Herpesvirus (HHV) type 1 and 2, and Dengue virus serotype 2 (DENV-2). The cytotoxicity on HeLa and Jurkat tumor cell lines was also tested. Using plaque forming unit assays, cell viability assays and molecular docking, we found that NQ 4 was the best antiviral compound, while AQ 11 was the most active and selective molecule on the tested tumor cells. NQ 4 showed a fair antiviral activity against Herpesviruses (EC50: <0.4 µg/mL, <1.28 µM) and DENV-2 (1.6 µg/mL, 5.1 µM) on pre-infective stages. Additionally, NQ 4 disrupted the viral attachment of HHV-1 to Vero cells (EC50: 0.12 µg/mL, 0.38 µM) with a very high selectivity index (SI = 1728). The in silico analysis predicted that this quinone could bind to the prefusion form of the E glycoprotein of DENV-2. These findings demonstrate that NQ 4 is a potent and highly selective antiviral compound, while suggesting its ability to prevent Herpes and Dengue infections. Additionally, AQ 11 can be considered of interest as a leader for the design of new anticancer agents.

16 March 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Rodrigo OchoaRodrigo Ochoa
Rodrigo Ochoa
Pilar CossioPilar Cossio
Pilar Cossio
Peptide research has increased during the last years due to their applications as biomarkers, therapeutic alternatives or as antigenic sub-units in vaccines. The implementation of computational resources have facilitated the identification of novel sequences, the prediction of properties, and the modelling of structures. However, there is still a lack of open source protocols that enable their straightforward analysis. Here, we present PepFun, a compilation of bioinformatics and cheminformatics functionalities that are easy to implement and customize for studying peptides at different levels: sequence, structure and their interactions with proteins. PepFun enables calculating multiple characteristics for massive sets of peptide sequences, and obtaining different structural observables derived from protein-peptide complexes. In addition, random or guided library design of peptide sequences can be customized for screening campaigns. The package has been created under the python language based on built-in functions and methods available in the open source projects BioPython and RDKit. We present two tutorials where we tested peptide binders of the MHC class II and the Granzyme B protease.

20 November 2013 in Bioinformatics
Verified
Journal Article
Open access
PDF file
Rodrigo OchoaRodrigo Ochoa
Rodrigo Ochoa
MDMark Davies
Mark Davies
GPGeorge Papadatos
George Papadatos
FAFrancis Atkinson
Francis Atkinson
JOJohn Overington
John Overington
Summary: myChEMBL is a completely open platform, which combines public domain bioactivity data with open source database and cheminformatics technologies. myChEMBL consists of a Linux (Ubuntu) Virtual Machine featuring a PostgreSQL schema with the latest version of the ChEMBL database, as well as the latest RDKit cheminformatics libraries. In addition, a self-contained web interface is available, which can be modified and improved according to user specifications. Availability and implementation: The VM is available at: ftp://ftp.ebi.ac.uk/pub/databases/chembl/VM/myChEMBL/current. The web interface and web services code is available at: https://github.com/rochoa85/myChEMBL. Contact:jpo@ebi.ac.uk